Member Info for Nlgb

Timster,

Re LDA asking for an update. You should be the first one to spot a running joke… 😉

@ Aldebaran,

We lost our patience ( and not patients) with you.

Get off here.

Aldebaran,

Honestly, just stay away if you’re only here to dump your ****

By the way, It’s PATIENTS we are talking about, patience is what we need with people like you..

I know, rule number 1: people who have not passed the 5000 -mark for posts yet are not allowed an opinion.

Watching,

What makes you think the sp will not drift down to 30p again? We’re well underway..

Junior1616,

That’s not how I read it: the 600k is revenue on the books for the full fin year as of August, suggesting higher potential for the full year but that’s not a given.

Changing subject Bella?

What you don’t seem to understand is that ii’s don’t want to touch this share because it’s so volatile hence it drifting south hence funding and debt repayments etc leading to bigger dilutions every time, reducing the value of your own long term holding (if there really is one…).

Lucius,

Totally agree. Thousands of posts about all the good (or bad) and then finally admitting they are just traders.

BV, I am sure we will.

Tempted to put in a big offer at £1 tomorrow morning but maybe not 🤓

Many would appreciate the jump though..

And overpaid by say £25 to do the demonstration..😏

Tried it out at 16.20 for 1620 shares and look what happened: sp jumped to 53p for a very short while. Now that’s what you call manipulation 😅

If a purchase order is instructed to an overseas bank with a maximum value, it can happen that those banks just put in an offer at that max rate. It has happened to me in the past. 60 p was reasonable yesterday morning.

Bline59

Well, 2.1m profit over a 2-week period is a bucket of gold to most..

It’s just mimicking.

Avacta is on a good run but that’s not a reason for kicking back at Hemo.

We’ll get there.

Aldebaran is a star.. literally

You are doing here exactly what you blame others for on the Avacta bb.. Hemo is worth to receive all the support it needs to overcome this difficult period from a financial point of view in order for it’s science to prevail and save lives. The vast majority on here want Vlad to succeed and eventually reap benefits.

I believe french Valneva has a chikungunya vaccine.

Goldman Sachs cut it’s forecast to 1.38. That’s probably why we see the drop.

GSA announced the 0.50% threshold for shorts on Apr 16 2024 when the shareprice was between 48.5 (19th) and 51.75 (12th). As someone suggested, was the temporary drop 2 days ago to let them out through the backdoor? If not, they are in the red now.

Aldebaran,

yes, you’re right. I should have said future expected Ebitda.